A Phase 1/2 Randomized, Placebo-Controlled Trial of Romidespin in Persons With HIV-1 on Suppressive Antiretroviral Therapy is a research paper published in The Journal of Infectious Diseases (2020). On theSindex it has a DataRank of 1.5. It has been cited 48 times, with 41 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
Repositories this paper deposited data in (declared in PubMed).
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.584
From this paper's citation signal
Citation Network Contribution
0.885
From 36 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 41 citers.
National Institutes of Health
Grant: UM1 AI068634
National Institutes of Health
Grant: UM1 AI068636
National Institutes of Health
Grant: UM1 AI106701
National Institutes of Health
Grant: UM1 AI069494
National Institutes of Health
Grant: UM1 AI069412
National Institutes of Health
Grant: UM1 AI069481
National Institutes of Health
Grant: UM1 AI069511
National Institutes of Health
Grant: UM1 AI069452
National Institutes of Health
Grant: UM1 AI069423
National Institutes of Health
Grant: UM1 AI069424
National Institutes of Health
Grant: UM1 AI069432
National Institutes of Health
Grant: UM1 AI069534
NIAID NIH HHS
Grant: P30 AI050410
National Institute of Allergy and Infectious Diseases
Celgene
FWCI
3.78
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals